Monoclonal antibodies and the midterms

Republicans are accusing the Biden administration of racism — against white people. (Do you know if it was the FDA or?) recommended that race and ethnicity be considered when deciding who gets the limited supply of monoclonal antibody treatments — including the only antibody treatment to effectively work against the Omicron variant. But, it's now become the latest political talking point for Republicans, looking to energize their base ahead of the midterm elections. Megan Messerly reports.